Quantitative structure-pharmacokinetic parameters relationships (QSPKR) analysis of antimicrobial agents in humans using simulated annealing k-nearest-neighbor and partial least-square analysis methods.
暂无分享,去创建一个
Alexander Tropsha | Yunde Xiao | A. Tropsha | Yunde Xiao | Chee Ng | Wendy Putnam | Bert Lum | B. Lum | C. Ng | W. Putnam
[1] J. Balian,et al. Interspecies scaling: a comparative study for the prediction of clearance and volume using two or more than two species. , 1996, Life sciences.
[3] W. S. St. Peter,et al. Clinical Pharmacokinetics of Antibiotics in Patients with Impaired Renal Function , 1992, Clinical pharmacokinetics.
[4] S. Ekins,et al. Three-dimensional quantitative structure activity relationship computational approaches for prediction of human in vitro intrinsic clearance. , 2000, The Journal of pharmacology and experimental therapeutics.
[5] S. P. Fodor,et al. Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions. , 1994, Journal of medicinal chemistry.
[6] W. Shelver,et al. Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks. , 1995, Journal of pharmaceutical sciences.
[7] Alexander Tropsha,et al. Novel Variable Selection Quantitative Structure-Property Relationship Approach Based on the k-Nearest-Neighbor Principle , 2000, J. Chem. Inf. Comput. Sci..
[8] P. Hinderling,et al. Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man , 1984, Journal of Pharmacokinetics and Biopharmaceutics.
[9] J H Lin,et al. Applications and limitations of interspecies scaling and in vitro extrapolation in pharmacokinetics. , 1998, Drug metabolism and disposition: the biological fate of chemicals.
[10] S. P. Fodor,et al. Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries. , 1994, Journal of medicinal chemistry.
[11] Alexander Tropsha,et al. Diversity and Coverage of Structural Sublibraries Selected Using the SAGE and SCA Algorithms , 2001, J. Chem. Inf. Comput. Sci..
[12] Quantitative relationships between structure and pharmacokinetic parameters using molecular connectivity chi indices I: Substituted 2-sulfapyridines. , 1984, Journal of pharmaceutical sciences.
[13] L. Aarons,et al. Quantitative Structure-Pharmacokinetics Relationships: I. Development of a Whole-Body Physiologically Based Model to Characterize Changes in Pharmacokinetics Across a Homologous Series of Barbiturates in the Rat , 1997, Journal of Pharmacokinetics and Biopharmaceutics.
[14] D J Rance,et al. The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data. , 1997, The Journal of pharmacology and experimental therapeutics.
[15] S. Campbell,et al. Long-acting dihydropyridine calcium antagonists. 4. Synthesis and structure-activity relationships for a series of basic and nonbasic derivatives of 2-[(2-aminoethoxy)methyl]-1,4-dihydropyridine calcium antagonists. , 1990, Journal of medicinal chemistry.
[16] P. Veng‐Pedersen,et al. Quantitative structure-pharmacokinetic relationships for systemic drug distribution kinetics not confined to a congeneric series. , 1994, Journal of pharmaceutical sciences.
[17] I Mahmood,et al. Interspecies scaling: predicting pharmacokinetic parameters of antiepileptic drugs in humans from animals with special emphasis on clearance. , 1996, Journal of pharmaceutical sciences.
[18] B. Kowalski,et al. Partial least-squares regression: a tutorial , 1986 .
[19] M Danhof,et al. Multivariate quantitative structure-pharmacokinetic relationships (QSPKR) analysis of adenosine A1 receptor agonists in rat. , 1999, Journal of pharmaceutical sciences.
[20] S. Toon,et al. Structure-pharmacokinetic relationships among the barbiturates in the rat. , 1983, The Journal of pharmacology and experimental therapeutics.